APA (7th ed.) Citation

XL, D., LM, S., MC, O., JM, Y., & BR, D. (2022). Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up. Journal of Alzheimer's disease & Parkinsonism, 12(3), .

Chicago Style (17th ed.) Citation

XL, Du, Simpson LM, Osani MC, Yama JM, and Davis BR. "Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up." Journal of Alzheimer's Disease & Parkinsonism 12, no. 3 (2022).

MLA (9th ed.) Citation

XL, Du, et al. "Risk of Developing Alzheimer's Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up." Journal of Alzheimer's Disease & Parkinsonism, vol. 12, no. 3, 2022.